Counseling plus buprenorphine-naloxone for opioid dependence [1]

New England Journal of Medicine

Volumn 355, Issue 16, 2006, Pages 1736-

  Gorelick, David A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; COCAINE; NALOXONE; OPIATE;

CLINICAL TRIAL; COUNSELING; DOSE RESPONSE; DRUG DEPENDENCE; HUMAN; LETTER; PRIORITY JOURNAL;

BUPRENORPHINE; COCAINE-RELATED DISORDERS; COMBINED MODALITY THERAPY; COUNSELING; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE;

EID: 33750071432     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc062301     Document Type: Letter

References (4)

1. Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med 2006;355:365-74.
2. Montoya ID, Schroeder JR, Preston KL, et al. Influence of psychotherapy attendance on buprenorphine treatment outcome. J Subst Abuse Treat 2005;28:247-54.
3. Schottenfeld RS, Pakes J, Ziedonis D, Kosten TR. Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biol Psychiatry 1993;34:66-74.
4. Montoya ID, Gorelick DA, Preston KL, et al. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence. Clin Pharmacol Ther 2004;75:34-48.